Ocugen (OCGN) EPS (Diluted) (QoQ) (2016 - 2025)
Ocugen (OCGN) EPS (Diluted) (QoQ) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -133.75% |
| Dec 31, 2023 | -465.15% |
| Sep 30, 2023 | 52.80% |
| Jun 30, 2023 | 4.48% |
| Mar 31, 2023 | 0.88% |
| Dec 31, 2022 | -1.01% |
| Sep 30, 2022 | 19.53% |
| Jun 30, 2022 | 22.77% |
| Mar 31, 2022 | -117.81% |
| Dec 31, 2021 | -38.20% |
| Sep 30, 2021 | 59.23% |
| Jun 30, 2021 | 56.37% |
| Mar 31, 2021 | -800.58% |
| Dec 31, 2020 | 54.35% |
| Sep 30, 2020 | 61.76% |
| Jun 30, 2020 | 32.58% |
| Mar 31, 2020 | -132.20% |
| Dec 31, 2019 | 102.42% |
| Sep 30, 2019 | -543.53% |
| Jun 30, 2019 | 62.33% |